PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Clinical trial NCT00766324 · COMPLETED

Trial details

NCT number: NCT00766324
Sponsor: Nerviano Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Hormone Refractory Prostate Cancer

Start date: 2007-09-01
Primary completion: 2011-03-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.